• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Med Imaging . Visual and quantitative assessment of COVID-19 pneumonia on chest CT: The relationship with disease severity and clinical finding

tetano

Editor, Senior Moderator
Curr Med Imaging


. 2021 Feb 15.
doi: 10.2174/1573405617666210215142528. Online ahead of print.
Visual and quantitative assessment of COVID-19 pneumonia on chest CT: The relationship with disease severity and clinical findings


Furkan Kaya[SUP] 1 [/SUP], Petek Şarlak Konya[SUP] 2 [/SUP], Emin Demirel[SUP] 1 [/SUP], Neşe Demirt?rk[SUP] 2 [/SUP], Semiha Orhan[SUP] 3 [/SUP], Furkan Ufuk[SUP] 4 [/SUP]



Affiliations

Abstract

Background: Lungs are the primary organ of involvement of COVID-19, and the severity of pneumonia in COVID-19 patients is an important cause of morbidity and mortality.
Aim: We aimed to evaluate the visual and quantitative pneumonia severity on chest computed tomography (CT) in patients with coronavirus disease 2019 (COVID-19) and compare the CT findings with clinical and laboratory findings.
Methods: We retrospectively evaluated adult COVID-19 patients who underwent chest CT, clinical scores, laboratory findings, and length of hospital stay. Two independent radiologists visually evaluated the pneumonia severity on chest CT (VSQS). Quantitative CT (QCT) assessment was performed using a free DICOM viewer, and the percentage of the well-aerated lung (%WAL), high-attenuation areas (%HAA) at different threshold values, and mean lung attenuation (MLA) values were calculated. The relationship between CT scores and the clinical, laboratory data, and length of hospital stay were evaluated in this cross-sectional study. The student's t-test and chi-square test were used to analyze the differences between variables. The Pearson correlation test analyzed the correlation between variables. The diagnostic performance of the variables was assessed using receiver operating characteristic (ROC) analysis was used.
Results: The VSQS and QCT scores were significantly correlated with procalcitonin, d-dimer, ferritin, and C-reactive protein levels. Both VSQ and QCT scores were significantly correlated with disease severity (p<0.001). Among the QCT parameters, the %HAA-600 value showed the best correlation with the VSQS (r=730,p<0.001). VSQS and QCT scores had high sensitivity and specificity in distinguishing disease severity and predicting prolonged hospitalization.
Conclusion: The VSQS and QCT scores can help manage the COVID-19 and predict the duration of hospitalization.

Keywords: CURB-65; Covid-19; Disease severity score; pneumonia; quantitative CT; visual CT.
 
Back
Top Bottom